BERQUIST JOSEPH A 4
4 · QUAKER CHEMICAL CORP · Filed May 11, 2023
Insider Transaction Report
Form 4
BERQUIST JOSEPH A
VP & Managing Director - NA
Transactions
- Exercise/Conversion
Common Stock
2023-05-10$136.64/sh+922$125,982→ 15,189 total - Exercise/Conversion
Common Stock
2023-05-10$178.29/sh+560$99,842→ 14,827 total - Sale
Common Stock
2023-05-10$210.00/sh−560$117,600→ 14,267 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-05-10−922→ 0 totalExercise: $136.64Exp: 2027-03-30→ Common Stock (922 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2023-05-10−560→ 2,472 totalExercise: $178.29Exp: 2029-03-16→ Common Stock (560 underlying) - Sale
Common Stock
2023-05-10$210.00/sh−922$193,620→ 14,267 total - Sale
Common Stock
2023-05-10$208.97/sh−453$94,662→ 13,814 total
Holdings
- 264(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]Information based on reporting person's Plan Statement as of March 31, 2023.
- [F2]The options for this grant vested in three annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023.
- [F3]The options for this grant vest in three annual installments: 1,010 shares on March 16, 2023; 1,011 shares on March 16, 2024; and 1,011 shares on March 16, 2025.